Clinical trial
A Randomized Trial of GM-CSF in Patients With ALI/ARDS
NCT00201409 · University of Michigan, Other · Completed
Key facts
| NCT number | NCT00201409 |
|---|---|
| Title | A Randomized Trial of GM-CSF in Patients With ALI/ARDS |
| Official title | A Randomized Trial of GM-CSF in Patients With ALI/ARDS |
| Lead sponsor | University of Michigan, Other |
| Collaborators | National Heart, Lung, and Blood Institute (NHLBI) NIH Emory University University of Colorado, Denver |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Respiratory Distress Syndrome, Adult |
| Intervention type | Drug |
| Interventions | Placebo, GM-CSF |
| Enrollment | 132 |
| Start date | Jul 1, 2004 |
| Primary completion | May 1, 2009 |
| Completion | Jun 1, 2009 |
| First posted | Sep 20, 2005 |
| Last update posted | Dec 29, 2015 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: